Swiss companies invested $27 billion in the U.S. between ‌January and April as Switzerland moves to fulfill a pledge to sharply increase investment following a tariff agreement with Washington, NZZ am Sonntag reported.

The figure was contained in an internal email from the Swiss-American Chamber ‌of Commerce to its members seen by the newspaper, ​it said.

Switzerland and the U.S. said on Nov. 14 that Swiss companies would invest $200 billion ⁠in the U.S. over the next five years. The ​pledge formed part of a preliminary agreement under which President ⁠Donald Trump reduced punitive tariffs on Swiss goods to 15% from 39%, after imposing the higher rate at the beginning of August.

The investors ‌include Novartis, which has announced two U.S. projects, including ​a biomedical research ‌center in San Diego and a cancer-drug production facility in Texas, while Roche is ‌expanding output in North Carolina. Medical technology company Ypsomed is building a new factory in the state.

Other investments include ⁠shipping group MSC's new ‌North American headquarters in ⁠Miami. The newspaper said this also covers spending on cruise and logistics operations.

Plus, machine tool maker Pfiffner Group and electronics firm Elma are expanding U.S. ‌production capacity.

"We are model students and we fulfill our promises," Swiss-American Chamber of Commerce CEO Rahul Sahgal said.

Washington last ‌week ​announced new tariffs against countries ‌it says are not doing enough to combat forced labor.

The U.S. plans a 12.5% tariff ​on Swiss goods under that measure compared with 10% for EU goods, the newspaper said.